Abstract: An apparatus, related devices and methods, having a memory element operable to store instructions; and a processor operable to execute the instructions, such that the apparatus is configured to identify, on an electronic device, a phone number of an incoming caller device; request, via an out-of-band control channel, a digital certificate for the phone number from the incoming caller device; receive, via the out-of-band control channel, the digital certificate for the phone number from the incoming caller device; determine whether the digital certificate for the phone number is authentic; and indicate, on the electronic device, based on a determination that the digital certificate for the phone number is authentic or not authentic, whether the phone number is authentic or not authentic.

Abstract: There is disclosed in an example, a gateway apparatus, including a hardware platform having a processor and a memory; a wireless network interface; and instructions encoded within the memory to instruct the processor to: provide a first virtual access point (VAP) secured by an IEEE 802.1x extensible authentication protocol (EAP) enterprise security method; provide a second VAP secured by a WiFi protected access pre-shared key (WPA-PSK) method; onboard a device, comprising determining whether the device supports the EAP method, and enrolling the device with the EAP method if the device supports the EAP method; and if the device does not support the EAP method, enrolling the device with the WPA-PSK method.

Abstract: Methods, apparatus, systems and articles of manufacture are disclosed to analyze telemetry data of a network device for malicious activity. An example apparatus includes an interface to obtain first telemetry data, a rules generator to, using the first telemetry data, generate a global block list using a machine learning model, the machine learning model generated based on a device specific block list and a device specific allow list, and a model manager to transmit the global block list to a gateway, the gateway to facilitate on-path classification of second telemetry data.

Abstract: Particular embodiments described herein provide for a system that can be configured to facilitate the use of a blockchain for distributed denial of service attack mitigation, the system can include a network security provider and a validating node. The network security provider can recognize that a distributed denial of service (DDoS) attack is occurring, create a block that includes data related to the DDoS attack, and publish the block that includes the data related to the DDoS attack for addition to a blockchain. The validating node can validate the block that includes the data related to the DDoS attack and the block that includes the data related to the DDoS attack can be added to the blockchain. The block that includes the data related to the DDoS attack can be analyzed to determine how to mitigate a similar DDoS attack.

Abstract: There is disclosed in one example a computing apparatus, including: a hardware platform including a processor, a memory, and a network interface; and instructions encoded within the memory to instruct the processor to: receive an incoming packet via the network interface; extract from the incoming packet a source port and a source internet protocol (IP) address; correlate the source port and source IP to a device identifier (ID); receive a network policy for the device ID; and apply the network policy to the incoming packet.

Abstract: An airbag assembly according to the present disclosure includes an airbag cushion and a first tether. The airbag cushion is configured to be stored in a roof of a vehicle when the airbag cushion is uninflated. The airbag cushion is configured to at least partially cover an opening in a sidewall of the vehicle when the airbag cushion is inflated. The first tether is coupled to a forward edge of the airbag cushion at a first location. The first tether is configured to be coupled to a body of the vehicle at a second location. A length of the first tether between the first and second locations is configured to vary as the airbag cushion is deployed.

Abstract: There is disclosed in one example an enrollment over secure transport (EST)-capable gateway device, including: a hardware platform including a processor and a memory; a first network interface to communicatively couple to an external network, including an external DNS server; a second network interface to communicatively couple to a home network; a caching DNS server including a local DNS cache, and logic to provide DNS services to the home network; and an EST proxy to authenticate to a local endpoint on the home network, provision a DNS server certificate on the local endpoint, provision an authentication domain name (ADN) on the local endpoint, and provide encrypted domain name system (DNS) services to the local endpoint.

Abstract: An airbag assembly according to the present disclosure includes an airbag cushion and a first tether. The airbag cushion is configured to be stored in a roof of a vehicle when the airbag cushion is uninflated. The airbag cushion is configured to at least partially cover an opening in a sidewall of the vehicle when the airbag cushion is inflated. The first tether is coupled to a forward edge of the airbag cushion at a first location. The first tether is configured to be coupled to a body of the vehicle at a second location. A length of the first tether between the first and second locations is configured to vary as the airbag cushion is deployed.

Abstract: Particular embodiments described herein provide for a system that can be configured to facilitate the use of a blockchain for distributed denial of service attack mitigation, the system can include a network security provider and a validating node. The network security provider can recognize that a distributed denial of service (DDoS) attack is occurring, create a block that includes data related to the DDoS attack, and publish the block that includes the data related to the DDoS attack for addition to a blockchain. The validating node can validate the block that includes the data related to the DDoS attack and the block that includes the data related to the DDoS attack can be added to the blockchain. The block that includes the data related to the DDoS attack can be analyzed to determine how to mitigate a similar DDoS attack.

Abstract: Mitigating channel congestion, or crowding, that degrades the performance capabilities of a venue-provided access point, or hotspot, can include identifying, with a mobile communication device, the venue-provided access point. Additionally, mitigating channel congestion can also include establishing a mobile hotspot with the mobile communication device. The mobile communication device can establish the mobile hotspot on a channel different from a channel used by the venue-provided access point. Mitigating channel congestion can also include reducing a signal radius of the mobile communication device by reducing transmission power of the mobile communication device.

Abstract: The present invention relates to an insecticidal enriched extract (biopesticide) isolated from the stem of Nothapodites foetida (Wight) Sleumer (formerly Mappia foetida (Miers) useful for the insect free storage and transport of grains and seed. The insecticidal activity of the enriched extract (biopesticide) of the invention is ascribed to compound/s other than camptothecin. The invention further relates to the process for preparation thereof, containing Compounds of general formula 1 and formula 2 (General formula 1) wherein R1=CH3, CH2OAC and wherein R2=COOH, or (I) and R3=H. OH.

Abstract: The present invention describes the use of pharmaceutical compositions including compounds of formula 2 (below) for treatment of infections related to M. tuberculosis and for anti-proliferative activity.

Abstract: The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I: wherein the variables are as defined herein.

Abstract: The present invention describes use of compounds of formula 1 or 2 or their compositions for the treatment of leukemia and use of compound of formula 1 or its composition for treatment of infections caused due to M. tuberculosis. The invention further discloses use of compound of formula 3 for the conversion of solar energy into electric current in dye sensitized solar cells.

Abstract: Aspects of an integrated circuit (IC) using a scaling voltage are provided. The IC includes a chip section configured to operate using a scaled supply voltage. The IC also includes a sensor configured to measure a temperature of the chip section. The IC also includes an adjustment circuit configured to adjust a supply voltage to a scaled supply voltage, wherein the scaled voltage is based on the measured temperature. Aspects of a testing device for a chip are also provided. The testing device includes a sensor configured to measure an operating frequency of a section of the chip when operating at a defined temperature. The testing device also includes a memory device comprising a scaled voltage table, the scaled voltage table configured to store as an entry the measured operating frequency and the defined temperature.

Abstract: Disclosed herein is a microbicidal composition comprising combination of selected extracts of aerial parts of plants such as Polygonum glabrum, Rhus mysorensis, Terminalia paniculata, Cuscuta reflexa, Terminalia crenulata, Scutia myrtina, and Cassytha filiformis along with pharmaceutically acceptable excipients or carriers, for the treatment of sexually transmitted diseases, particularly HSV-2 type infections.

Abstract: The invention relates to morpholine spirocyclic piperidine amide compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

Abstract: Active fractions exhibiting anti-tuberculous activity from the plant Byttneria herbecea (family—Sterculiaceae) are described. Methanol extracts of the aerial part of Byttneria herbecea exhibited activity against MtbGS in primary screening of biosynthetic assay. Subsequent fractionation was carried out in organic solvents. Out of all these, two fractions (fraction D and K) are exhibiting inhibitory activity against M. tuberculosis glutamine synthetase activity. These fractions D and K are inhibiting 74% and 44% respectively at 7.5 mg/ml concentrations. The determined IC50 value of the fraction K is found to be 4.5 mg/ml from the dose response curve against the purified Mycobacterium tuberculosis Glutamine Synthetase. The IC50 value for M. bovis BCG is 1.56 ?g/ml. It was observed that there was no significant effect on proliferation of HL-60 cell line at 10×MIC levels of the hits. This data indicated that these compounds could be initially considered to be safe.

Abstract: This invention discloses diterpenes class of novel compounds of general formula I from a novel source. More particularly the invention relates to extracts/fractions containing pimarane diterpenes from Anisochillus (Lamiaceae), useful for prevention, treatment, inhibition or controlling growth and proliferation of mycobacterial activity in mammals. The invention further relates to extracts, fractions standardized to diterpenes class of novel compounds useful for the treatment of cancers.

Abstract: The present invention describes use of compounds of formula 1 or 2 or their compositions for the treatment of leukemia and use of compound of formula 1 or its composition for treatment of infections caused due to M. tuberculosis. The invention further discloses use of compound of formula 3 for the conversion of solar energy into electric current in dye sensitized solar cells.